Standardization of Shirodhara
Phase 2
Recruiting
- Registration Number
- CTRI/2017/08/009580
- Lead Sponsor
- SRI DHARMASTHALA MANJUNATHESHWARA COLLEGE OF AYURVEDA AND HOSPITAL HASSA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Healthy subjects between the age group of 20-60 of either sex
Whose routine clinical examiation and laboratory investigations reveal no abnormality
Patient willing to sign on Informed consent form
Exclusion Criteria
Persons who are having habit of consuming Alcohol and tobacco
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the therapeutic effects of Takradhara in clinical trials?
How does Takradhara compare to standard-of-care treatments for its target conditions in terms of efficacy and safety?
Are there specific biomarkers that can predict patient response to Takradhara therapy?
What are the known adverse events associated with Takradhara and how can they be managed?
What are the potential combination therapies or competitor interventions for Takradhara in the context of its clinical application?